Improving detection combined with targeted therapy for small hepatocellular carcinoma

Affiliations

Editorial

Shengyang Qiu et al. Ann Transl Med. 2019 Mar.

. 2019 Mar;7(Suppl 1):S4.

doi: 10.21037/atm.2019.01.19.

¹ HPB Surgical Unit, Department of Surgery & Cancer, Imperial College, London, UK.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Percutaneous US/MRI Fusion-guided Radiofrequency Ablation for Recurrent Subcentimeter Hepatocellular Carcinoma: Technical Feasibility and Therapeutic Outcomes.
Song KD, Lee MW, Rhim H, Kang TW, Cha DI, Sinn DH, Lim HK. Song KD, et al. Radiology. 2018 Sep;288(3):878-886. doi: 10.1148/radiol.2018172743. Epub 2018 Jun 19. Radiology. 2018. PMID: 29916771

1. Tateishi R, Shiina S, Teratani T, et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 2005;103:1201-9. 10.1002/cncr.20892 - DOI - PubMed
1. Choi D, Lim HK, Kim MJ, et al. Recurrent hepatocellular carcinoma: percutaneous radiofrequency ablation after hepatectomy. Radiology 2004;230:135-41. 10.1148/radiol.2301021182 - DOI - PubMed
1. Shiina S, Tateishi R, Arano T, et al. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors. Am J Gastroenterol 2012;107:569-77; quiz 78. 10.1038/ajg.2011.425 - DOI - PMC - PubMed
1. Lee MW, Kim YJ, Park HS, et al. Targeted sonography for small hepatocellular carcinoma discovered by CT or MRI: factors affecting sonographic detection. AJR Am J Roentgenol 2010;194:W396-400. 10.2214/AJR.09.3171 - DOI - PubMed
1. Song KD, Lee MW, Rhim H, et al. Fusion imaging-guided radiofrequency ablation for hepatocellular carcinomas not visible on conventional ultrasound. AJR Am J Roentgenol 2013;201:1141-7. 10.2214/AJR.13.10532 - DOI - PubMed